MD Rawlins

35 papers and 673 indexed citations i.

About

MD Rawlins is a scholar working on Pharmacology, Pharmacology and Oncology. According to data from OpenAlex, MD Rawlins has authored 35 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 10 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in MD Rawlins’s work include Pharmacogenetics and Drug Metabolism (8 papers), Inflammatory mediators and NSAID effects (5 papers) and Pharmaceutical studies and practices (4 papers). MD Rawlins is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Inflammatory mediators and NSAID effects (5 papers) and Pharmaceutical studies and practices (4 papers). MD Rawlins collaborates with scholars based in United Kingdom, Trinidad and Tobago and Portugal. MD Rawlins's co-authors include R. A. Seymour, H. Ashton, PA Routledge, K. W. Woodhouse, O.F.W. James, D. Nicholas Bateman, C. A. Edwards, Sam Shuster, P C Adams and JC Mucklow and has published in prestigious journals such as British Journal of Clinical Pharmacology and Ecosystem Services.

In The Last Decade

Co-authorship network of co-authors of MD Rawlins i

Fields of papers citing papers by MD Rawlins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MD Rawlins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MD Rawlins. The network helps show where MD Rawlins may publish in the future.

Countries citing papers authored by MD Rawlins

Since Specialization
Citations

This map shows the geographic impact of MD Rawlins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MD Rawlins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MD Rawlins more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025